\-\ Texto\\:\\ \ \(0\)\
\-\ estropia\\ of\\ the\\ left\\ eye\\,\\ 6th\\ cranial\\ nerve\\ palsy\\ of\\ the\\ right\\ eye\\,\\ tongue\\ deviates\\ to\\ the\\ right\\ on\\ extension\\.\\ \\ hemoglobin\\ of\\ 9\\.7\\ hematocrit\\ of\\ 28\\.9\\ and\\ esr\\ of\\ 80\\.\\ otherwise\\ labs\\ are\\ within\\ normal\\ limits\\.\ \(0\)\
\-\ the\\ patient\\ is\\ undergoing\\ chemotherapy\\ according\\ to\\ cog\\ high\\ risk\\ renal\\ tumor\\ protocol\\.\ \(0\)\
\-\ \\â\\€\\¢\\ large\\ heterogenous\\ mass\\ of\\ the\\ right\\ kidney\\,\\ intraspinal\\ mass\\ at\\ t10\\,\\ bony\\ irregularity\\ of\\ c7\\,\\ t1\\,\\ and\\ t11\\.\ \(0\)\
\-\ \\â\\€\\¢\\ bone\\ marrow\\ of\\ the\\ calvarium\\,\\ skull\\ base\\,\\ and\\ clivus\\ are\\ infiltrated\\ with\\ abnormal\\ enhancing\\ soft\\ tissue\\ extending\\ into\\ the\\ epidural\\ spaces\\ and\\ right\\ cavernous\\ sinus\\.\ \(0\)\
\-\ \\â\\€\\¢\\ right\\ renal\\ mass\\ with\\ increased\\ uptake\\ also\\ noted\\ in\\ the\\ bilateral\\ calvarium\\,\\ skull\\ base\\,\\ clivus\\,\\ c1\\,\\ c2\\,\\ c7\\,\\ t1\\,\\ t11\\,\\ right\\ scapula\\,\\ proximal\\ right\\ humerus\\,\\ right\\ first\\ and\\ anterior\\ fifth\\ ribs\\,\\ left\\ acetabulum\\,\\ left\\ femur\\ and\\ right\\ tibia\\.\ \(0\)\
\-\ clear\\ cell\\ sarcoma\\ of\\ the\\ kidney\ \(0\)\
\-\ \\â\\€\\¢\\ clear\\ cell\\ sarcoma\\,\ \(0\)\
\-\ \\â\\€\\¢\\ malignant\\ rhabdoid\\ tumor\ \(0\)\
\-\ \\â\\€\\¢\\ rhabdomyosarcoma\ \(2\)\
\-\ \\â\\€\\¢\\ wilms\\ tumor\ \(0\)\
\-\ \\â\\€\\¢\\ pnet\ \(0\)\
\-\ \\â\\€\\¢\\ neuroblastoma\\.\ \(0\)\
\-\ 10\\ year\\ old\\ boy\\ with\\ dysphagia\\,\\ weight\\ loss\\,\\ slurred\\ speech\\ and\\ double\\ vision\\.\\ \\ there\\ is\\ no\\ significant\\ past\\ medical\\ history\\.\ \(0\)\
\-\ clear\\ cell\\ sarcoma\\ of\\ the\\ kidney\\ is\\ a\\ neoplasm\\ of\\ childhood\\ with\\ a\\ propensity\\ to\\ metastasize\\ to\\ bone\\.\\ \\ in\\ fact\\,\\ it\\ was\\ previously\\ called\\ bone\\ metastasizing\\ renal\\ tumor\\ of\\ childhood\\.\\ \\ it\\ less\\ frequently\\ metastasizes\\ to\\ lung\\,\\ abdomen\\,\\ retroperitoneum\\,\\ brain\\,\\ and\\ liver\\.\\ as\\ a\\ result\\,\\ both\\ conventional\\ radiographic\\ and\\ scintigraphic\\ skeletal\\ survey\\ are\\ recommended\\.\\ \\ it\\ represents\\ 3\\%\\ of\\ pediatric\\ renal\\ tumors\\ and\\ has\\ a\\ slight\\ male\\ predominance\\.\\ \\ \ \(0\)\
\-\ the\\ usual\\ presentation\\ is\\ abdominal\\ mass\\ noted\\ by\\ a\\ caregiver\\.\\ \\ physical\\ findings\\ typically\\ include\\ a\\ palpable\\ unilateral\\ abdominal\\ mass\\.\\ \\ hypertension\\ and\\ hematuria\\ are\\ also\\ associated\\ findings\\.\ \(0\)\
\-\ the\\ origin\\ of\\ clear\\ cell\\ sarcoma\\ has\\ not\\ been\\ established\\,\\ however\\,\\ the\\ cell\\ of\\ origin\\ has\\ been\\ suggested\\ to\\ be\\ renal\\ mesenchymal\\ with\\ neural\\ markers\\.\\ \\ \ \(0\)\
\-\ the\\ imaging\\ findings\\ typically\\ demonstrate\\ a\\ large\\ unicentric\\ mass\\ that\\ markedly\\ distorts\\ or\\ replaces\\ the\\ kidney\\.\\ \\ cystic\\ foci\\ are\\ typically\\ present\\ as\\ well\\ as\\ foci\\ of\\ necrosis\\ and\\ hemorrhage\\.\\ \\ as\\ previously\\ stated\\,\\ there\\ is\\ a\\ propensity\\ for\\ the\\ tumor\\ to\\ metastasize\\ to\\ bone\\ as\\ in\\ this\\ case\\.\ \(0\)\
\-\ at\\ presentation\\,\\ radical\\ nephrectomy\\ is\\ the\\ initial\\ treatment\\ of\\ choice\\ if\\ the\\ tumor\\ is\\ resectable\\,\\ along\\ with\\ chemotherapy\\ and\\ radiatio\\.\\ \\ if\\ the\\ lesion\\ is\\ not\\ resectable\\ then\\ chemotherapy\\ is\\ administered\\ and\\ an\\ attempt\\ at\\ resection\\ may\\ be\\ made\\ if\\ the\\ tumor\\ responds\\ to\\ therapy\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ sarcoma\\:\\ 0\\.034433331492038394\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.031907532046070115\ \(0\)\
\-\ tumor\\:\\ 0\\.031551190297003796\ \(0\)\
\-\ propensity\\:\\ 0\\.03108420033896464\ \(0\)\
\-\ resectable\\:\\ 0\\.03108420033896464\ \(0\)\
\-\ renal\\:\\ 0\\.029043841057217978\ \(0\)\
\-\ clear\\:\\ 0\\.028593001023951545\ \(0\)\
\-\ t11\\:\\ 0\\.02794778775724543\ \(0\)\
\-\ metastasize\\:\\ 0\\.027343573310980623\ \(0\)\
\-\ kidney\\:\\ 0\\.027243289185972942\ \(0\)\
\-\ calvarium\\:\\ 0\\.026113104010149664\ \(0\)\
\-\ clivus\\:\\ 0\\.026113104010149664\ \(0\)\
\-\ cell\\:\\ 0\\.026111320266758893\ \(0\)\
\-\ c7\\:\\ 0\\.024499190236671235\ \(0\)\
\-\ childhood\\:\\ 0\\.021756494292914152\ \(0\)\
\-\ \\,\\:\\ 0\\.020823851193637492\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.020789224786023974\ \(0\)\
\-\ typically\\:\\ 0\\.02047347807356995\ \(0\)\
\-\ estropia\\:\\ 0\\.01994461181892873\ \(0\)\
\-\ unicentric\\:\\ 0\\.01994461181892873\ \(0\)\
\-\ radiatio\\:\\ 0\\.01994461181892873\ \(0\)\
\-\ bone\\:\\ 0\\.01921660345212552\ \(0\)\
\-\ 9\\.7\\:\\ 0\\.018376405528069125\ \(0\)\
\-\ 80\\.\\:\\ 0\\.018376405528069125\ \(0\)\
\-\ metastasizes\\:\\ 0\\.018376405528069125\ \(0\)\
\-\ caregiver\\:\\ 0\\.018376405528069125\ \(0\)\
\-\ distorts\\:\\ 0\\.018376405528069125\ \(0\)\
\-\ right\\:\\ 0\\.018359016701343326\ \(0\)\
\-\ origin\\:\\ 0\\.0177270525973556\ \(0\)\
\-\ 28\\.9\\:\\ 0\\.017459063654521243\ \(0\)\
\-\ cog\\:\\ 0\\.017459063654521243\ \(0\)\
\-\ deviates\\:\\ 0\\.016808199237209522\ \(0\)\
\-\ metastasizing\\:\\ 0\\.016808199237209522\ \(0\)\
\-\ foci\\:\\ 0\\.01659739342603188\ \(0\)\
\-\ skull\\:\\ 0\\.016467731635260947\ \(0\)\
\-\ previously\\:\\ 0\\.016243311087118992\ \(0\)\
\-\ eye\\:\\ 0\\.016219048900958877\ \(0\)\
\-\ mass\\:\\ 0\\.01613295484544205\ \(0\)\
\-\ if\\:\\ 0\\.015738077604845944\ \(0\)\
\-\ replaces\\:\\ 0\\.01554210016948232\ \(0\)\
\-\ base\\:\\ 0\\.015146870058060485\ \(0\)\
\-\ responds\\:\\ 0\\.014973515490113753\ \(0\)\
\-\ infiltrated\\:\\ 0\\.014735143282743106\ \(0\)\
\-\ as\\:\\ 0\\.014621917487490133\ \(0\)\
\-\ rhabdoid\\:\\ 0\\.014322651072802032\ \(0\)\
\-\ retroperitoneum\\:\\ 0\\.014141558973993126\ \(0\)\
\-\ t10\\:\\ 0\\.013973893878622716\ \(0\)\
\-\ slurred\\:\\ 0\\.013973893878622716\ \(0\)\
\-\ intraspinal\\:\\ 0\\.013534626877625074\ \(0\)\
\-\ presentation\\:\\ 0\\.013318554907199468\ \(0\)\
\-\ c1\\:\\ 0\\.013282985169230902\ \(0\)\
\-\ are\\:\\ 0\\.01317730625033486\ \(0\)\
\-\ mesenchymal\\:\\ 0\\.013056552005074832\ \(0\)\
\-\ it\\:\\ 0\\.013037432474205995\ \(0\)\
\-\ markers\\:\\ 0\\.012850733502346943\ \(0\)\
\-\ scapula\\:\\ 0\\.012754444781942426\ \(0\)\
\-\ 6th\\:\\ 0\\.012662087328276691\ \(0\)\
\-\ scintigraphic\\:\\ 0\\.012487967325706267\ \(0\)\
\-\ findings\\:\\ 0\\.012345047075497464\ \(0\)\
\-\ c2\\:\\ 0\\.012326295461493268\ \(0\)\
\-\ t1\\:\\ 0\\.01225563591051694\ \(0\)\
\-\ predominance\\:\\ 0\\.012103580364630705\ \(0\)\
\-\ radical\\:\\ 0\\.012103580364630705\ \(0\)\
\-\ acetabulum\\:\\ 0\\.011966420586765468\ \(0\)\
\-\ wilms\\:\\ 0\\.011966420586765468\ \(0\)\
\-\ survey\\:\\ 0\\.011900837924156301\ \(0\)\
\-\ established\\:\\ 0\\.011837102908394546\ \(0\)\
\-\ tongue\\:\\ 0\\.01177511427900967\ \(0\)\
\-\ hemoglobin\\:\\ 0\\.01177511427900967\ \(0\)\
\-\ pnet\\:\\ 0\\.011714778878371296\ \(0\)\
\-\ is\\:\\ 0\\.011449359740865455\ \(0\)\
\-\ hematocrit\\:\\ 0\\.011383096810063885\ \(0\)\
\-\ usual\\:\\ 0\\.011282527211487339\ \(0\)\
\-\ speech\\:\\ 0\\.011139588520035909\ \(0\)\
\-\ administered\\:\\ 0\\.011139588520035909\ \(0\)\
\-\ attempt\\:\\ 0\\.011093881037417087\ \(0\)\
\-\ conventional\\:\\ 0\\.010962050928539316\ \(0\)\
\-\ nephrectomy\\:\\ 0\\.010962050928539316\ \(0\)\
\-\ has\\:\\ 0\\.010891628759010936\ \(0\)\
\-\ rhabdomyosarcoma\\:\\ 0\\.010878247146457076\ \(0\)\
\-\ according\\:\\ 0\\.010758089170633664\ \(0\)\
\-\ palsy\\:\\ 0\\.010719413982037962\ \(0\)\
\-\ fifth\\:\\ 0\\.010607203707966984\ \(0\)\
\-\ stated\\:\\ 0\\.0105353740737711\ \(0\)\
\-\ been\\:\\ 0\\.010519433888977336\ \(0\)\
\-\ ribs\\:\\ 0\\.010431732589537406\ \(0\)\
\-\ protocol\\:\\ 0\\.010398214295905863\ \(0\)\
\-\ irregularity\\:\\ 0\\.010332631633296695\ \(0\)\
\-\ fact\\:\\ 0\\.010176539163869205\ \(0\)\
\-\ called\\:\\ 0\\.010146572587511692\ \(0\)\
\-\ choice\\:\\ 0\\.010002419161298777\ \(0\)\
\-\ humerus\\:\\ 0\\.009947234878212445\ \(0\)\
\-\ heterogenous\\:\\ 0\\.009920139423355621\ \(0\)\
\-\ suggested\\:\\ 0\\.00984074729708578\ \(0\)\
\-\ esr\\:\\ 0\\.009789325914557374\ \(0\)\
\-\ neural\\:\\ 0\\.009789325914557374\ \(0\)\
\-\ neuroblastoma\\:\\ 0\\.009665664347729627\ \(0\)\
\-\ abdominal\\:\\ 0\\.009664792932679255\ \(0\)\
\-\ unilateral\\:\\ 0\\.009594586980685783\ \(0\)\
\-\ skeletal\\:\\ 0\\.009548413062968119\ \(0\)\
\-\ epidural\\:\\ 0\\.009525674746557482\ \(0\)\
\-\ spaces\\:\\ 0\\.009525674746557482\ \(0\)\
\-\ undergoing\\:\\ 0\\.00948087242235798\ \(0\)\
\-\ dysphagia\\:\\ 0\\.009415289759748813\ \(0\)\
\-\ double\\:\\ 0\\.009351554743987056\ \(0\)\
\-\ pediatric\\:\\ 0\\.009310040855597472\ \(0\)\
\-\ represents\\:\\ 0\\.009289566114602183\ \(0\)\
\-\ hematuria\\:\\ 0\\.00917046264517815\ \(0\)\
\-\ noted\\:\\ 0\\.009164801757704044\ \(0\)\
\-\ markedly\\:\\ 0\\.009151207691178357\ \(0\)\
\-\ slight\\:\\ 0\\.00909440696463746\ \(0\)\
\-\ cavernous\\:\\ 0\\.008967167782911496\ \(0\)\
\-\ vision\\:\\ 0\\.008932090437807502\ \(0\)\
\-\ tibia\\:\\ 0\\.008880473519784491\ \(0\)\
\-\ to\\:\\ 0\\.008695956959246326\ \(0\)\
\-\ marrow\\:\\ 0\\.008505141671081878\ \(0\)\
\-\ large\\:\\ 0\\.008454943130457375\ \(0\)\
\-\ cranial\\:\\ 0\\.008406452479959954\ \(0\)\
\-\ frequently\\:\\ 0\\.00837902858735284\ \(0\)\
\-\ femur\\:\\ 0\\.008351933132496017\ \(0\)\
\-\ recommended\\:\\ 0\\.00801474856425962\ \(0\)\
\-\ limits\\:\\ 0\\.007968809048058838\ \(0\)\
\-\ at\\:\\ 0\\.007858120946821038\ \(0\)\
\-\ bony\\:\\ 0\\.00773157403268947\ \(0\)\
\-\ made\\:\\ 0\\.007701068715184296\ \(0\)\
\-\ uptake\\:\\ 0\\.007680957974421295\ \(0\)\
\-\ necrosis\\:\\ 0\\.007631449577929197\ \(0\)\
\-\ also\\:\\ 0\\.0076227130935300974\ \(0\)\
\-\ hypertension\\:\\ 0\\.007621676588914453\ \(0\)\
\-\ result\\:\\ 0\\.0074167062374388285\ \(0\)\
\-\ radiographic\\:\\ 0\\.0073379284882098056\ \(0\)\
\-\ tumors\\:\\ 0\\.007261801714186654\ \(0\)\
\-\ a\\:\\ 0\\.007178276955992784\ \(0\)\
\-\ sinus\\:\\ 0\\.0070704954064308555\ \(0\)\
\-\ risk\\:\\ 0\\.007002729971400648\ \(0\)\
\-\ malignant\\:\\ 0\\.006987942706740501\ \(0\)\
\-\ nerve\\:\\ 0\\.006965941462640964\ \(0\)\
\-\ otherwise\\:\\ 0\\.0069441521118243105\ \(0\)\
\-\ weight\\:\\ 0\\.0069297415953413245\ \(0\)\
\-\ extension\\:\\ 0\\.006901193034347633\ \(0\)\
\-\ then\\:\\ 0\\.006880015562040927\ \(0\)\
\-\ palpable\\:\\ 0\\.006852083806786857\ \(0\)\
\-\ labs\\:\\ 0\\.006723923092613436\ \(0\)\
\-\ liver\\:\\ 0\\.006665659526770868\ \(0\)\
\-\ neoplasm\\:\\ 0\\.006584064651384453\ \(0\)\
\-\ boy\\:\\ 0\\.006571768732864189\ \(0\)\
\-\ less\\:\\ 0\\.006547375575390685\ \(0\)\
\-\ 10\\:\\ 0\\.00651724938540025\ \(0\)\
\-\ extending\\:\\ 0\\.006499364363890944\ \(0\)\
\-\ left\\:\\ 0\\.006489402280132906\ \(0\)\
\-\ first\\:\\ 0\\.00648751908322591\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.0064349696474570945\ \(0\)\
\-\ initial\\:\\ 0\\.00640629444180839\ \(0\)\
\-\ along\\:\\ 0\\.006389262164838272\ \(0\)\
\-\ the\\:\\ 0\\.006255623742245511\ \(0\)\
\-\ past\\:\\ 0\\.006142985230648042\ \(0\)\
\-\ enhancing\\:\\ 0\\.0060632432870695915\ \(0\)\
\-\ resection\\:\\ 0\\.006029220940090993\ \(0\)\
\-\ be\\:\\ 0\\.005962700105628639\ \(0\)\
\-\ medical\\:\\ 0\\.005948664706031685\ \(0\)\
\-\ brain\\:\\ 0\\.005817537383037924\ \(0\)\
\-\ proximal\\:\\ 0\\.005804396338703654\ \(0\)\
\-\ there\\:\\ 0\\.00575436903377823\ \(0\)\
\-\ abdomen\\:\\ 0\\.0057271137169585895\ \(0\)\
\-\ and\\:\\ 0\\.005701642715500132\ \(0\)\
\-\ loss\\:\\ 0\\.0056119098924625336\ \(0\)\
\-\ lung\\:\\ 0\\.005599907511852367\ \(0\)\
\-\ not\\:\\ 0\\.005587414804262151\ \(0\)\
\-\ cystic\\:\\ 0\\.005576092097854658\ \(0\)\
\-\ abnormal\\:\\ 0\\.005513783349128759\ \(0\)\
\-\ include\\:\\ 0\\.005423424181063998\ \(0\)\
\-\ however\\:\\ 0\\.005383185646147219\ \(0\)\
\-\ high\\:\\ 0\\.005290828192481484\ \(0\)\
\-\ significant\\:\\ 0\\.005198749210529917\ \(0\)\
\-\ therapy\\:\\ 0\\.005168870579729894\ \(0\)\
\-\ anterior\\:\\ 0\\.00497916928453108\ \(0\)\
\-\ both\\:\\ 0\\.004937104051326067\ \(0\)\
\-\ physical\\:\\ 0\\.004743224591812757\ \(0\)\
\-\ increased\\:\\ 0\\.004729603578732253\ \(0\)\
\-\ soft\\:\\ 0\\.004707979104057806\ \(0\)\
\-\ bilateral\\:\\ 0\\.00469189531519105\ \(0\)\
\-\ into\\:\\ 0\\.004600285900361328\ \(0\)\
\-\ tissue\\:\\ 0\\.004582400878852022\ \(0\)\
\-\ associated\\:\\ 0\\.004562132493003851\ \(0\)\
\-\ imaging\\:\\ 0\\.004529578788361093\ \(0\)\
\-\ 3\\:\\ 0\\.00452709395182475\ \(0\)\
\-\ \\%\\:\\ 0\\.004509776093543004\ \(0\)\
\-\ of\\:\\ 0\\.004480915415307247\ \(0\)\
\-\ demonstrate\\:\\ 0\\.004448986745097377\ \(0\)\
\-\ well\\:\\ 0\\.0043734863189336\ \(0\)\
\-\ present\\:\\ 0\\.004366535642379369\ \(0\)\
\-\ may\\:\\ 0\\.004240561920583991\ \(0\)\
\-\ case\\:\\ 0\\.004229648038161247\ \(0\)\
\-\ lesion\\:\\ 0\\.003937907751132251\ \(0\)\
\-\ treatment\\:\\ 0\\.003913160542083455\ \(0\)\
\-\ within\\:\\ 0\\.0036880801094707734\ \(0\)\
\-\ male\\:\\ 0\\.003495940130967134\ \(0\)\
\-\ that\\:\\ 0\\.003339322915291456\ \(0\)\
\-\ by\\:\\ 0\\.003219164939468043\ \(0\)\
\-\ normal\\:\\ 0\\.0030307974085952514\ \(0\)\
\-\ in\\:\\ 0\\.0028601621955220923\ \(0\)\
\-\ an\\:\\ 0\\.002673449919196222\ \(0\)\
\-\ history\\:\\ 0\\.002670168637346343\ \(0\)\
\-\ or\\:\\ 0\\.0022658885723160806\ \(0\)\
\-\ was\\:\\ 0\\.0022359219959585674\ \(0\)\
\-\ this\\:\\ 0\\.0021745185821586722\ \(0\)\
\-\ year\\:\\ 0\\.002163134093377635\ \(0\)\
\-\ old\\:\\ 0\\.0019794900381498973\ \(0\)\
\-\ no\\:\\ 0\\.0019467062233117693\ \(0\)\
\-\ patient\\:\\ 0\\.0019379907939284797\ \(0\)\
\-\ \\.\\:\\ 0\\.0018472609281424534\ \(0\)\
\-\ for\\:\\ 0\\.0016495659471554643\ \(0\)\
\-\ on\\:\\ 0\\.0016377624714149959\ \(0\)\
\-\ with\\:\\ 0\\.0015882919831206753\ \(0\)\
